Cutaneous manifestations in SARS‐CoV‐2 infection (COVID‐19): a French experience and a systematic review of the literature

Sara Matar1, Bénédicte Oulès2,1,3, Pierre Sohier4,3, Olivier Chosidow5,6, M. Beylot‐Barry7,8, N. Dupin2,1,3,9, S. Aractingi2,1,3,9
1Department of Dermatology Hôpital Cochin AP‐HP Groupe Hospitalier Paris Centre Cochin‐Hôtel Dieu‐Broca Paris France
2Cutaneous Biology Lab INSERM U1016 UMR8104 Institut Cochin Paris France
3Faculté de Médecine Paris Centre Santé University of Paris Paris France
4Department of Pathology Hôpital Cochin AP‐HP Groupe Hospitalier Paris Centre Cochin‐Hôtel Dieu‐Broca Paris France
5Department of Dermatology Hôpital Henri Mondor AP‐HP Hôpitaux Universitaires Henri Mondor Créteil France
6Research Group Dynamyc EA7380 Faculté de Médecine Université Paris‐Est Créteil Ecole nationale vétérinaire d'Alfort USC ANSES Créteil France
7Bordeaux Research in Translational Oncology, INSERM U1053, Bordeaux, France
8Department of Dermatology, CHU Bordeaux, Bordeaux, France
9These authors contributed equally to this work as co-senior authors.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1001/jamadermatol.2020.1704

10.1111/jdv.16533

10.1111/jdv.16526

10.1016/j.jaad.2020.05.120

10.1111/bjd.19163

10.1056/NEJMoa2002032

10.1111/jdv.16387

Masson A, 2020, Chilblains are a common cutaneous finding during the COVID‐19 pandemic: a retrospective nationwide study from France, J Am Acad Dermatol

10.1111/jdv.16530

10.1111/jdv.16519